Efficacy and Safety of Insulin Glargine vs. NPH Insulin in Subjects With Type 2 Diabetes Mellitus Uncontrolled on Oral Agents: A Pooled Analysis of RCT Data

被引：0
|
作者：
Bolli, Geremia B.
Porcellati, Francesca
Lin, Jay
Wang, Edward
Lucidi, Paolo
Fanelli, Carmine G.
机构：
来源：
DIABETES | 2012年 / 61卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1033-P
引用
收藏
页码：A265 / A265
页数：1
相关论文
共 50 条
  • [11] Comparison of Safety and Efficacy of Insulin Glargine and Neutral Protamine Hagedorn Insulin in Older Adults with Type 2 Diabetes Mellitus: Results from a Pooled Analysis
    Lee, Pearl
    Chang, Annette
    Blaum, Caroline
    Vlajnic, Aleksandra
    Gao, Ling
    Halter, Jeffrey
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2012, 60 (01) : 51 - 59
  • [12] Duration of diabetes and hypoglycaemia rates in type 2 diabetes patients treated with insulin glargine vs NPH insulin
    Dailey, G.
    Aurand, L.
    Garg, S.
    DIABETOLOGIA, 2011, 54 : S262 - S262
  • [13] Efficacy and Safety of Exenatide QW vs. Placebo Added to Insulin Glargine in Uncontrolled Basal-Insulin Treated Type 2 Diabetes: DURATION-7 Trial
    Frias, Juan P.
    Rosenstock, Julio
    Somogyi, Aniko
    Jabbour, Serge A.
    Wang, Hui
    Hardy, Elise
    Guja, Cristian
    DIABETES, 2017, 66 : A34 - A35
  • [14] Systematic review and meta-analysis of randomized clinical trials comparing efficacy and safety outcomes of insulin glargine with NPH insulin, premixed insulin preparations or with insulin detemir in type 2 diabetes mellitus
    Przemyslaw Rys
    Piotr Wojciechowski
    Agnieszka Rogoz-Sitek
    Grzegorz Niesyczyński
    Joanna Lis
    Albert Syta
    Maciej T. Malecki
    Acta Diabetologica, 2015, 52 : 649 - 662
  • [15] Systematic review and meta-analysis of randomized clinical trials comparing efficacy and safety outcomes of insulin glargine with NPH insulin, premixed insulin preparations or with insulin detemir in type 2 diabetes mellitus
    Rys, Przemyslaw
    Wojciechowski, Piotr
    Rogoz-Sitek, Agnieszka
    Niesyczynski, Grzegorz
    Lis, Joanna
    Syta, Albert
    Malecki, Maciej T.
    ACTA DIABETOLOGICA, 2015, 52 (04) : 649 - 662
  • [16] Safety and efficacy of insulin glargine (HOE 901) versus NPH insulin in combination with oral treatment in Type 2 diabetic patients
    Pfeiffer, C
    Winkler, F
    Luger, A
    Pieber, T
    Saudek, F
    Skrha, J
    Hermansen, K
    Lervang, HH
    Nistrup-Holmegaard, S
    Bergkulla, S
    Lembcke, HJ
    Schulze, J
    Petersen, KG
    Haslbeck, M
    Jonker, JJC
    Vaaler, S
    Rolstad, OJ
    Distiller, LA
    Robertson, LI
    Omar, MAK
    Wing, J
    Arner, P
    Arnqvist, H
    Lager, I
    Lennerhagen, P
    Borthwick, LJ
    Hattersley, A
    Owens, DR
    Matthews, DR
    Nattrass, M
    DIABETIC MEDICINE, 2003, 20 (07) : 545 - 551
  • [17] Effect of insulin glargine and NPH on quality of life in patients with type 2 diabetes mellitus
    Gupta, K.
    Gupta, U.
    Singh, N.
    VALUE IN HEALTH, 2006, 9 (06) : A237 - A237
  • [18] Pharmacoeconomic analysis of insulin glargine compared with NPH insulin in patients with type 2 diabetes in Spain
    Terres, CR
    Rodríguez, J
    Bolinder, B
    De Pablos, P
    DIABETES, 2004, 53 : A291 - A291
  • [19] Efficacy and safety of insulin glargine in children and adolescents with Type 1 diabetes mellitus
    Peterkova, VA
    Kuraeva, TL
    Scherbacheva, LN
    Andrianova, EA
    Maximova, VF
    Titovich, V
    DIABETOLOGIA, 2004, 47 : A297 - A297
  • [20] Safety and efficacy of insulin detemir vs. insulin NPH in pregnant women with diabetes: a systematic review and meta-analysis
    Fatima, Kaneez
    Siddiqi, Ahmed K.
    Shakil, Saad
    Akhtar, Sareema E.
    Quraishy, Maryam S.
    Siddiqui, Khadija
    Rafique, Esha
    Maniya, Muhammad T.
    MINERVA OBSTETRICS AND GYNECOLOGY, 2023,
12345